2013-09-26 10:33:04 -
Professor Schultz's work has resulted in new methods to synthesize molecules
with novel chemical and biological properties and has impacted chemistry,
materials science and medicine
Brussels, 26 September 2013 -- The "Chemistry for the Future Solvay Prize", a
bi-annual EUR 300,000 prize created by the Belgium based Solvay Group, is
awarded to Professor Peter G. Schultz, professor at the Scripps Research
Institute in California, and Director of the California Institute for
The formal statement of the jury chaired by Hakan Wennerström, Professor at
the University of Lund,
motivates the decision as follows: "For Professor
Schultz's multiple scientific contributions at the interface between chemistry
and biology, in particular for the exploitation of molecular diversity and the
rational expansion of the genetic code of the living organisms."
Professor Schultz's ground breaking work is impacting many scientific fields,
including biotechnology and medicine. It also has important implications for
regenerative medicine, and the treatment of infectious disease, autoimmune
disease and cancer.
Unanimous in their decision, the five jury members of the Solvay Prize,
amongst them two Nobel prize winners, took into account several criteria
including scientific excellence, potential and actual scientific and societal
impact, and scientific activity. Professor Schultz successfully delivered on
all these requirements and proved to be a worthy winner.
In his most recent work, Professor Schultz pioneered a method that enables the
expansion of the genetic codes of living organisms to include new building
blocks beyond the 20 amino acids common to all forms of life. This ability,
demonstrated with over seventy synthetic amino acids, has created new powerful
tools in protein engineering, cell biology and biochemistry. Professor
Schultz's ground breaking work is impacting many scientific fields, including
biotechnology and medicine.
His early work exploited the molecular diversity of the immune system to
develop antibodies that selectively catalyze chemical reactions, much like
natural enzymes. He extended these combinatorial concepts to many areas of
chemistry, biology and medicine, and was the first to apply this approach to
materials science, which made it possible to simultaneously synthesize and
characterize the properties of many different materials for use in electronic
devices, catalysis, energy storage and the environment. More recently, by
developing highly sophisticated methods to screen "chemical libraries" for
their effects on living cells, Schultz's team identified small, biologically
active molecules with important implications for regenerative medicine and the
treatment of infectious disease, autoimmune disease and cancer.
Professor Schultz is known for his pro-activity, publishing during the course
of his career over 500 papers and training over 300 co-workers. In addition,
he has set up ten different pioneering technology companies and biomedical
research institutes to ensure the positive impact of his scientific research
"I am obviously delighted to win the Solvay Prize", said Professor Schultz.
"It is a wonderful recognition for all of the hard work of a terrific group of
present and past co-workers. I am very much looking forward to travelling to
Belgium on 4 December for the award ceremony."
The Chemistry for the Future Solvay Prize rewards a major scientific discovery
that could shape tomorrow's chemistry and help human progress. The EUR
300,000 Prize will be awarded every two years. It was announced on the
occasion of the 150th anniversary of the creation of the chemical company
Solvay by Ernest Solvay, and to perpetuate the founder's commitment as a
strong supporter of scientific research. It is intended to endorse basic
research and underline the essential role of chemistry as a science and an
industry to help solve some of the most pressing issues the world is facing.
The prize will be given to Professor Peter G. Schultz during an award ceremony
at the Palais des Académies in Brussels, Belgium, on 4 December 2013.
|As an international chemical group, SOLVAY assists industries in finding and|
|implementing ever more responsible and value-creating solutions. The Group|
|is firmly committed to sustainable development and focused on innovation and|
|operational excellence. Solvay serves diversified markets, generating 90% of|
|its turnover in activities where it is one of the top three worldwide. The|
|Group is headquartered in Brussels, employs about 29,000 people in 55 |
|countries and generated 12.4 billion euros in net sales in 2012. Solvay SA|
|SOLB.BE) is listed on NYSE EURONEXT in Brussels and Paris (Bloomberg:|
|SOLB.BB - Reuters: SOLBt.BR). |
LAMIA NARCISSE CAROLINE JACOBS MARIA ALCON-HIDALGO EDWARD MACKAY
Media Relations Media Relations Investor Relations Investor Relations
+ 33 1 53 56 59 62 + 32 2 264 1530 + 32 2 264 1984 + 32 2 264 3687
You can find here the press release in PDF:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Solvay S.A. via Thomson Reuters ONE